Premium Domain Acquisition
OrganLabs.com — the defining domain name for the frontier of human medicine. Artificial organs, 3D bioprinting, organ-on-chip platforms, regenerative medicine and the biotech revolution transforming how humanity treats organ failure.
Science Coverage
OrganLabs.com encompasses the complete scientific and commercial landscape of synthetic and regenerative organ technology — from bench-top bioprinting to clinical-stage artificial organ implants.
Layer-by-layer bioprinting of living tissue using bio-inks containing human cells, growth factors and hydrogels. Functional ear, tracheal and liver tissue structures have already been printed — with full organs on the horizon.
Total artificial hearts, ventricular assist devices, kidney dialysis-replacing implants and artificial lungs. Electromechanical devices that replicate organ function without biological tissue — the bridge to transplant and beyond.
Microfluidic devices lined with living human cells that replicate organ physiology for drug testing. Replacing animal models across pharma, eliminating billions in failed clinical trials and accelerating time-to-market for new therapeutics.
Decellularised scaffolds, stem cell seeding, induced pluripotent stem cells and growth factor-guided regeneration. Building living replacement organs from a patient's own cells to eliminate rejection risk entirely.
Drug discovery, organ toxicity testing, personalised medicine validation and preclinical trial platforms using bioprinted and lab-grown organ models. A $270B+ industry being transformed by synthetic organ technology.
Regulatory pathways, FDA clearance strategies, GMP manufacturing scale-up and hospital integration for artificial and bioprinted organ products. The bridge from laboratory breakthrough to bedside life-saving intervention.
● Category-defining .com ● Available for acquisition ●
OrganLabs.com captures the imagination in two words. It evokes the laboratory precision of cutting-edge science and the ultimate object of that science — the organ. No other domain in this space combines scientific authority, commercial clarity and consumer memorability with the same economy. This is the name that media will cite, researchers will recognise, and investors will remember.
Request Acquisition TermsWho Acquires This Domain?
OrganLabs.com delivers immediate authority across the full spectrum of life sciences, medical technology and biotech innovation.
A company developing 3D bioprinting technology for organ fabrication — whether hardware, bio-ink, software or full organ systems — benefits from a domain that positions them as the laboratory of the organ manufacturing revolution.
A manufacturer of artificial hearts, ventricular assist devices, kidney replacement implants or artificial lungs. OrganLabs.com signals innovation-led engineering at the frontier of life-saving medical device technology.
A pharma company or CRO using organ-on-chip and bioprinted organ models for drug discovery, toxicity testing and personalised medicine trials. The domain anchors a platform that replaces animal models across the $270B R&D industry.
A university spinout, research hospital or NIH-funded centre working on tissue engineering, regenerative medicine or synthetic biology. OrganLabs.com provides a commercial-grade digital home for world-class academic research.
A venture capital firm or investment platform focused on life sciences, regenerative medicine and medical technology. OrganLabs.com as a portfolio tracking or thought leadership hub signals deep sector expertise to founders and LPs alike.
A science journalism publication, industry newsletter or research intelligence service covering the organ technology revolution. OrganLabs.com is the natural editorial home for the scientists, clinicians and investors defining this field.
A digital health platform improving organ donor matching, transplant logistics, waitlist management or post-transplant patient monitoring. OrganLabs.com communicates clinical depth and technological sophistication simultaneously.
A clinical network or private health operator offering stem cell therapies, regenerative treatments and organ health programmes. OrganLabs.com positions any clinical offering as scientifically rigorous and innovation-led from day one.
The Scientific Imperative
The organ shortage crisis is one of the most urgent unmet needs in modern medicine. Over 100,000 patients in the United States alone sit on transplant waiting lists. Globally, the gap between organ supply and demand affects an estimated 1.5 million patients annually. Thousands die waiting each year for a heart, kidney, liver or lung that never arrives.
The solution to this crisis will come from laboratories — from the scientists, engineers and clinicians developing artificial organs, bioprinted tissue structures and regenerative therapies that can replace, repair or bypass the need for donor organs entirely. This is the work of organ labs.
The domain OrganLabs.com names this entire scientific and commercial mission in two words. It is the most evocative, most memorable and most scientifically resonant name available to any organisation working at this frontier — and it is available for acquisition now.
Why This Domain
Research Intelligence
Lead Research · 3D Bioprinting · Clinical Translation
The first 3D-printed ear was successfully implanted in a human patient in 2022. Functional vascularised liver tissue has been demonstrated at laboratory scale. A bioprinted kidney that produces urine in a living host has been shown to be within reach. The organ printing revolution is not approaching — it has arrived. The question is how fast it scales.
Read Full Research →Artificial Organs
Organ-on-Chip
Domain Strategy
● Premium .com — available for acquisition today ●